Ketamine Archives

Psychedelics News

Ketamine

Finance

18 Oct 2023

Spravato Sales Lead J&J Third Quarter Results

Johnson & Johnson has released its 3rd quarter results and once again Spravato sales have shown impressive growth....

By Jason Najum

Science

13 Oct 2023

FDA Issues Warning Letter for Ketamine

The FDA has issued a warning letter regarding the use of ketamine outside of FDA-approved conditions....

By Jason Najum

Science

6 Oct 2023

New Study Shows Spravato Effective When Combined With SSRIs

A new study published in the New England Journal of Medicine found that Spravato’s esketamine was more effective than a commonly prescribed drug in treating treatment-resistant depression....

By Jason Najum

Industry

21 Sep 2023

Seelos Therapeutics Announces Results from Phase II Depression Trial

Seelos Therapeutics has released results from its SLS-002 Phase II study of adults with Major Depressive Disorder at Imminent Risk of Suicide....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Breaking News

10 Aug 2023

Christian Angermayer Gives Insight on Future of Atai’s Ketamine Program

Christain Angermayer gave some clarification on PCN-101, atai's ketamine program, hinting at new direction for the compound....

By Jason Najum

Breaking News, Industry

9 Aug 2023

atai Life Sciences Announces Results of New Phase 1 Study of PCN-101 (R-Ketamine)

Atai announced results from Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous bridging study of PCN-101 (R-ketamine)....

By Microdose NewsDesk

Industry

4 Aug 2023

Affordable Ketamine Treatments: Interview With Dr. Bryan Henry of PsychMD

We sat down with PsychMD founder Bryan Henry to discuss the company’s ambitious roll-out and focus on affordable ketamine treatments....

By Microdose

Science

20 Jul 2023

New Study Shows Ketamine Effective Against Treatment-Resistant Depression

Results from a phase 3 trial show that generic ketamine was safe and effective in treating patients with treatment-resistant depression....

By Microdose NewsDesk

Finance

4 Jul 2023

The Commercial Market for Legal Psychedelics: Spravato

Spravato provides insights into market potential of legal psychedelics - we take a closer look....

By Jason Najum

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result